ACHE and early-onset autosomal dominant Alzheimer disease: Inhibitions of AChE decrease the hydrolysis of ACh in the brain and increase cholinergic neurotransmissions, which might be helpful in treating mild to moderate levels of Alzheimer's disease [17].